Don’t Sleep Through Cephalon’s Growth
Cephalon (CEPH) is a biopharmaceutical company that we have highlighted in the past, and they reported another outstanding quarter after the close on Tuesday. The company’s most successful drug is Provigil, which is used to treat some sleep disorders, but for some reason we think the market has been lulled into sleepiness when it comes to this growth story.
The company reported revenue of $712.4 million, or 32% growth over the second quarter last year. Adjusted for income per share came in at $2.20 per share, 41% better than a year ago and $.43 cents better than Wall Street expected (that is after 9 analysts upped their targets in just the last month). The company experienced growth in all different categories of drugs with oncology drug Treanda being a standout from the bunch.
Not only was last quarter a successful one for Cephalon, but they also raised full year earnings guidance for the second straight quarter. Now the company expects earnings per share of between $7.45 and $7.65 on sales of $2.63 billion to $2.71 billion. Analysts’ estimates are calling for $2.73 billion which may provide some reasoning behind the market’s lackluster response to the earnings report. In fact, at the time of writing the stock is trading off nearly 3% in after hours. Management’s outlook for the third quarter is also viewed as conservative on the revenue side, but exceeds profit estimates.
The last time we wrote about Cephalon (Cephalon Still Undervalued After Outstanding Quarter) they had just reported a great first quarter, yet still the stock is trading at about the same price level. We have to urge value investor to view this stock as an opportunity, and not miss the forest for the trees. The company has a history of offering uninspiring revenue guidance and then consistently outpaces it. Meanwhile, their profitability continues to surge higher, and after five years averaging nearly 26% EPS growth, the company now trades for less than 9x this year’s earnings.
Even the sales forecasts that have spooked the market are priced attractively in our view. For example, over the last ten years the market has been willing to pay between 2.23x and 3.56x revenue per share for Cephalon, but at management’s current estimations—which are likely conservative—the stock is trading at a price-to-sales multiple of just 1.75x. For all of these reasons, we have placed an Undervalued rating on Cephalon and will not downgrade it based on the improving fundamentals seen in this earnings report. We think Cephalon is a growth stock that a value investor can appreciate, and investors with a long term focus ought to take a serious look. With its established drugs as well as its promising pipeline, we think it may be a takeover target with many of the mega-drug companies facing serious patent cliffs in the next couple of years.
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Lion’s Mane Mushroom
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes:
Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.
Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.
Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.
Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.
Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules. Today Be 100% Satisfied Or Receive A Full Money Back Guarantee Order Yours Today By Following This Link.